Prescription Narcotics Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026 Prescription narcotics are a type of drug that has the potential to be addictive. Because of their addictive potential, this type of drug should only be used according to a doctor’s specific prescription. These narcotics are also used as pain killers to relieve pain from the body and this narcotic work in the body by binding themselves to pain receptors in the nervous system so that the pain signals are blocked. As a result, this type of drug is sometimes prescribed to temporarily treat severe pain that doesn’t respond to other forms of pain relievers. Increasing demand of opioids in clinical practice for treating chronic pain conditions is fuelling the growth of the market. Along with increasing demand, rising prevalence of chronic pain is expected to boost the utilization of narcotics in effective chronic pain treatment. According to CDC, 11% of adult population in the US is experiencing some form of chronic pain. Further, changing regulatory conditions to encourage the utilization of narcotics in better management of pain led to potential growth of the market. Further, opioids are only available effective therapy for severe pains when compared to alternatives treatment options. All these factors led to potential growth of the market during forecast period. Global market is dominated by North America market due to supportive regulatory environment. It is expected to remain dominant throughout forecast period and it witnessed a large number of manufacturers. It is followed by Europe market due to high adoption of opioids for effective management of pain. Asia Pacific and Latin America is fast growing region due to increasing adoption of opioids in clinical practice. Further, high prevalence of chronic pain in these regions is expected fuel the growth of the market. Rest of World is also fast-growing region due to increasing adoption among end-user segment led to potential growth of the market. Prescription Narcotics market players include Pfizer Inc, Novartis AG, J&J, Merck Co. & Inc, Roche Holding, Bayer AG, AstraZeneca, Sanofi Plc and others Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=214&page=requestsample Prescription Narcotics Market Segmentation By Indication + Cancer Pain + Trauma + Analgesics + Others By Sales Channel + Retail Pharmacies + Institutional Distribution By Region + North America + Latin America + Europe + Asia Pacific + Rest of the World Purchase a Copy of this Premium Research Report & Ask For Discount: https://www.futurewiseresearch.com/requestsample.aspx?id=214&page=askfordiscount Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global Prescription Narcotics Market by Indication, by Sales Channel, and by Region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions • Profiling of companies to evaluate their market shares, strategies, financials and core competencies Table of Contents 1. Introduction 1.1.1.1. Scope and Objective 1.1.1.2. Assumptions and Acronyms 1.1.1.3. Forecast Factors 1.1.1.4. Research Methodology 2. Executive Summary 2.1.1.1. Industry Cluster Analysis 2.1.1.2. Competition Matrix 2.1.1.3. Strategies Recommendations 3. Market Definition 3.1.1.1. Report Scope (Inclusions & Exclusions) 3.1.1.2. Market Segmentation 4. Global Prescription Narcotics Market Overview 4.1.1.1. Global Prescription Narcotics Market Revenue (USD Mn) 5. Key Inclusions 5.1.1.1. Porter’s Five Force analysis 5.1.1.2. Market Dynamics 5.1.1.3. Industry Trends 5.1.1.4. Regulatory Guidelines 5.1.1.5. Opportunities in Prescription Narcotics 6. Competition Dynamics 6.1.1.1. Company Share Analysis (2018) 6.1.1.2. Top 10 Product Pricing by Region 7. Global Prescription Narcotics Market Revenue (USD Mn), 2018-2026 by Indication 7.1.1.1. Key Market Findings 7.1.1.2. Long Term ROI Segments 7.1.1.3. Revenue Opportunity Influencing Factors 7.1.1.4. Market Revenue (USD Mn) Assessment and Forecast by Indication, 2018-2026 7.1.1.4.1.1. Cancer Pain 7.1.1.4.1.2. Trauma 7.1.1.4.1.3. Analgesics 7.1.1.4.1.4. Others 8. Global Prescription Narcotics Market Revenue (USD Mn), 2018-2026 by Sales Channel 8.1.1.1. Key Market Findings 8.1.1.2. Long Term ROI Segments 8.1.1.3. Revenue Opportunity Influencing Factors 8.1.1.4. Market Revenue (USD Mn) Assessment and Forecast by Sales Channel, 2018-2026 8.1.1.4.1.1. Retail Pharmacies 8.1.1.4.1.2. Institutional Distribution 9. Global Prescription Narcotics Market Revenue (USD Mn), 2018-2026 by Region 9.1.1.1. Key Market Findings 9.1.1.2. Long Term ROI Segments 9.1.1.3. Revenue Opportunity Influencing Factors 9.1.1.4. Market Revenue (USD Mn) Assessment and Forecast by Region,2026 9.1.1.4.1.1. North America 9.1.1.4.1.2. Latin America 9.1.1.4.1.3. Europe 9.1.1.4.1.4. Asia Pacific 9.1.1.4.1.5. Rest of world 10. North America Prescription Narcotics Market Revenue (US$ Mn), 2018-2026 10.1.1.1. Key Market Findings 10.1.1.2. Long Term ROI Segments 10.1.1.3. Revenue Opportunity Influencing Factors 10.1.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026 10.1.1.4.1.1. US 10.1.1.4.1.2. Canada 10.1.1.5. Market Revenue (USD Mn) Assessment and Forecast by Indication, 2018-2026 10.1.1.5.1.1. Cancer Pain 10.1.1.5.1.2. Trauma 10.1.1.5.1.3. Analgesics 10.1.1.5.1.4. Others 10.1.1.6. Market Revenue (USD Mn) Assessment and Forecast by Sales Channel, 2018-2026 10.1.1.6.1.1. Retail Pharmacies 10.1.1.6.1.2. Institutional Distribution 11. Latin America Prescription Narcotics Market Revenue (US$ Mn), 2018-2026 11.1.1.1. Key Market Findings 11.1.1.2. Long Term ROI Segments 11.1.1.3. Revenue Opportunity Influencing Factors 11.1.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026 11.1.1.4.1.1. Brazil 11.1.1.4.1.2. Mexico 11.1.1.4.1.3. Argentina 11.1.1.4.1.4. Rest of Latin America 11.1.1.5. Market Revenue (USD Mn) Assessment and Forecast by Indication, 2018-2026 11.1.1.5.1.1. Cancer Pain 11.1.1.5.1.2. Trauma 11.1.1.5.1.3. Analgesics 11.1.1.5.1.4. Others 11.1.1.6. Market Revenue (USD Mn) Assessment and Forecast by Sales Channel, 2018-2026 11.1.1.6.1.1. Retail Pharmacies 11.1.1.6.1.1.1. Institutional Distribution 12. Europe America Prescription Narcotics Market Revenue (US$ Mn), 2018-2026 12.1.1.1. Key Market Findings 12.1.1.2. Long Term ROI Segments 12.1.1.3. Revenue Opportunity Influencing Factors 12.1.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026 12.1.1.4.1.1. Germany 12.1.1.4.1.2. France 12.1.1.4.1.3. Spain 12.1.1.4.1.4. UK 12.1.1.4.1.5. Russia 12.1.1.4.1.6. Poland 12.1.1.4.1.7. Rest of Europe 12.1.1.5. Market Revenue (USD Mn) Assessment and Forecast by Indication, 2018-2026 12.1.1.5.1.1. Cancer Pain 12.1.1.5.1.2. Trauma 12.1.1.5.1.3. Analgesics 12.1.1.5.1.4. Others 12.1.1.6. Market Revenue (USD Mn) Assessment and Forecast by Sales Channel, 2018-2026 12.1.1.6.1.1. Retail Pharmacies 12.1.1.6.1.2. Institutional Distribution 13. Asia Pacific America Prescription Narcotics Market Revenue (US$ Mn), 20182026 13.1.1.1. Key Market Findings 13.1.1.2. Long Term ROI Segments 13.1.1.3. Revenue Opportunity Influencing Factors 13.1.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026 13.1.1.4.1.1. Emerging Asia 13.1.1.4.1.1.1.1. China 13.1.1.4.1.1.1.2. India 13.1.1.4.1.1.1.3. ASEAN-5 13.1.1.4.1.1.1.4. Rest of Emerging Asia 13.1.1.4.1.2. Japan 13.1.1.5. Market Revenue (USD Mn) Assessment and Forecast by Indication, 2018-2026 13.1.1.5.1.1. Cancer Pain 13.1.1.5.1.2. Trauma 13.1.1.5.1.3. Analgesics 13.1.1.5.1.4. Others 13.1.1.6. Market Revenue (USD Mn) Assessment and Forecast by Sales Channel, 2018-2026 13.1.1.6.1.1. Retail Pharmacies 13.1.1.6.1.2. Institutional Distribution 14. Rest of World America Prescription Narcotics Market Revenue (US$ Mn), 20182026 14.1.1.1. Key Market Findings 14.1.1.2. Long Term ROI Segments 14.1.1.3. Revenue Opportunity Influencing Factors 14.1.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country, 2018-2026 14.1.1.4.1.1. Middle East 14.1.1.4.1.2. South Africa 14.1.1.4.1.3. North Africa 14.1.1.4.1.4. Rest of World 14.1.1.5. Market Revenue (USD Mn) Assessment and Forecast by Indication, 2018-2026 14.1.1.5.1.1. Cancer Pain 14.1.1.5.1.2. Trauma 14.1.1.5.1.3. Analgesics 14.1.1.5.1.4. Others 14.1.1.6. Market Revenue (USD Mn) Assessment and Forecast by Sales Channel, 2018-2026 14.1.1.6.1.1. Retail Pharmacies 14.1.1.6.1.1.1. Institutional Distribution 15. Company Profiles 15.1.1.1. Competition Landscape 15.1.1.2. Global Company Share (USD Mn) Overview, 2018 15.1.1.3. Company Profiles 15.1.1.3.1.1. Pfizer Inc 15.1.1.3.1.1.1.1. Corporate Overview 15.1.1.3.1.1.1.2. Financial Performance 15.1.1.3.1.1.1.3. Peer Comparison & 3C marketing equation 15.1.1.3.1.1.1.4. Company Strategy & Channel Management 15.1.1.3.1.2. Novartis AG 15.1.1.3.1.2.1.1. Corporate Overview 15.1.1.3.1.2.1.2. Financial Performance 15.1.1.3.1.2.1.3. Peer Comparison & 3C marketing equation 15.1.1.3.1.2.1.4. Company Strategy & Channel Management 15.1.1.3.1.3. J&J 15.1.1.3.1.3.1.1. Corporate Overview 15.1.1.3.1.3.1.2. Financial Performance 15.1.1.3.1.3.1.3. Peer Comparison & 3C marketing equation 15.1.1.3.1.3.1.4. Company Strategy & Channel Management 15.1.1.3.1.4. Merck Co. & Inc 15.1.1.3.1.4.1.1. Corporate Overview 15.1.1.3.1.4.1.2. Financial Performance 15.1.1.3.1.4.1.3. Peer Comparison & 3C marketing equation 15.1.1.3.1.4.1.4. Company Strategy & Channel Management 15.1.1.3.1.5. Roche Holding 15.1.1.3.1.5.1.1. Corporate Overview 15.1.1.3.1.5.1.2. Financial Performance 15.1.1.3.1.5.1.3. Peer Comparison & 3C marketing equation 15.1.1.3.1.5.1.4. Company Strategy & Channel Management 15.1.1.3.1.6. Bayer AG 15.1.1.3.1.6.1.1. Corporate Overview 15.1.1.3.1.6.1.2. Financial Performance 15.1.1.3.1.6.1.3. Peer Comparison & 3C marketing equation 15.1.1.3.1.6.1.4. Company Strategy & Channel Management 15.1.1.3.1.7. AstraZeneca 15.1.1.3.1.7.1.1. Corporate Overview 15.1.1.3.1.7.1.2. Financial Performance 15.1.1.3.1.7.1.3. Peer Comparison & 3C marketing equation 15.1.1.3.1.7.1.4. Company Strategy & Channel Management 15.1.1.3.1.8. Sanofi Plc 15.1.1.3.1.8.1.1. Corporate Overview 15.1.1.3.1.8.1.2. Financial Performance 15.1.1.3.1.8.1.3. Peer Comparison & 3C marketing equation 15.1.1.3.1.8.1.4. Company Strategy & Channel Management 16. Research Sources & Primary Verbatim Inquire further details about this report at: [email protected] About FutureWise Research: We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future. Contact Us: Company Name: FutureWise Research Contact Person: Vinay Thaploo Email: [email protected] Phone: +44 141 628 9353 / +1 970 279 4295 City: Leeds Country: United Kingdom Website: www.futurewiseresearch.com
Prescription narcotics are a type of drug that has the potential to be addictive. Because of their addictive potential, this type of drug should only be used according to a doctor’s specific prescription. These narcotics are also used as pain killers to relieve pain from the body and this narcotic work in the body by binding themselves to pain receptors in the nervous system so that the pain signals are blocked. As a result, this type of drug is sometimes prescribed to temporarily treat severe pain that doesn’t respond to other forms of pain relievers.
© Copyright 2024 Paperzz
